Bio-Rad Laboratories, Inc. · NYSE:BIO

Bio-Rad Laboratories — Technical Presentation (2022)

129 slides from Bio-Rad Laboratories's technical presentation, Dec 14, 2022

  1. Slide 1: CRISPR Gene Editing: Bio-Rad's Out of the Blue CRISPR Kit

    explorer.bio-rad.com CRISPR Gene Editing Bio-Rad’s Out of the Blue CRISPR Kit

  2. Slide 2: Local Hands on Training and Support

    explorer.bio-rad.com Damon_Tighe@Bio-Rad.com 510-282-4480 Local Hands on Training Guest Speaking (via Zoom) Account Management / Quotes Technical Support 2

  3. Slide 3: Workshop agenda

    explorer.bio-rad.com Workshop agenda 1. lacZ gene 2. Hands-on Lab 3. CRISPR-Cas9 overview 4. Experimental setup 5. Predictions & Controls

  4. Slide 4: What is CRISPR?

    explorer.bio-rad.com What is CRISPR? • Highly precise way to edit genomes • Relatively cheap and easy to use • Nobel prize in 2020 – Jennifer Doudna and Emmanuelle Charpentier

  5. Slide 5: Goal of Lab: Use CRISPR to disrupt lacZ

    explorer.bio-rad.com Goal of Lab: Use CRISPR to disrupt lacZ lacZ lacZ

  6. Slide 6: lacZ Beta-galactosidase

    explorer.bio-rad.com lacZ Beta-galactosidase

  7. Slide 7: lacZ Beta-galactosidase Lactose

    explorer.bio-rad.com lacZ Beta-galactosidase Lactose Galactose Glucose

  8. Slide 8: lacZ Beta-galactosidase X-gal

    explorer.bio-rad.com lacZ Beta-galactosidase X-gal Blue pigment

  9. Slide 9: Key Knowledge lacZ Beta-galactosidase

    Key Knowledge explorer.bio-rad.com lacZ Beta-galactosidase X-gal Blue pigment

  10. Slide 10: Work Flow

    explorer.bio-rad.com Work Flow Prep cells and CRISPR Heat Shock Plate transformants components

  11. Slide 11: Tube transformation solution

    explorer.bio-rad.com transformati Tube bacteria plasmid on solution A 250 µl B 250 µl 250 µl C 250 µl D 250 µl

  12. Slide 12: Tube transformation solution

    explorer.bio-rad.com transformati Tube bacteria plasmid on solution 5 colonies from A 250 µl IX plate 5 colonies from B 250 µl IX plate 5 colonies from C 250 µl IX-Ara plate 5 colonies from D 250 µl IX-Ara plate

  13. Slide 13: Tube transformation solution

    explorer.bio-rad.com transformati Tube bacteria plasmid on solution 5 colonies from A 250 µl 10 µl pD IX plate 5 colonies from B 250 µl 10 µl pDG IX plate 5 colonies from C 250 µl 10 µl pD IX-Ara plate 5 colonies from D 250 µl 10 µl pDG IX-Ara plate

  14. Slide 14: Flick tubes to mix, and put back on ice

    explorer.bio-rad.com • Flick tubes to mix, and put back on ice. • Keep on ice at least 10 minutes.

  15. Slide 15: Clustered Regularly Interspaced Palindromic Repeats

    explorer.bio-rad.com Clustered Regularly Interspaced Palindromic Repeats

  16. Slide 16: Clustered Regularly Interspaced Palindromic Repeats

    explorer.bio-rad.com Clustered Regularly Interspaced Palindromic Repeats Palindromic segments CGTTGAAGCGTCCGAAATTACGCTTCAACG GCAACTTCGCAGGCTTTAATGCGAAGTTGC repeat repeat repeat repeat

  17. Slide 17: Clustered Regularly Interspaced Palindromic Repeats

    explorer.bio-rad.com Clustered Regularly Interspaced Palindromic Repeats repeat spacer repeat spacer repeat spacer repeat

  18. Slide 18: Clustered Regularly Interspaced Palindromic Repeats

    explorer.bio-rad.com Clustered Regularly Interspaced Palindromic Repeats spacer spacer spacer

  19. Slide 19: Acquire Foreign DNA Sequences, Defend against Future Infection

    explorer.bio-rad.com Acquire Foreign DNA Sequences Defend against Future Infection 1. Acquire if if 4. Cleave Cas9 spacer DNA — DNA from from viral infection | infection Cas9 proteins with processed Cas1 and Cas2 complex guide RNA (gRNA) Process RNA and form Cas9 complexes 2. Add spacer 3. Transcrib

  20. Slide 20: Store guide information, Protect with guide information

    explorer.bio-rad.com Store guide information Protect with guide information

  21. Slide 21: crRNA + tracRNA

    explorer.bio-rad.com crRNA + tracRNA 20-nucleotide guiding region scaffold region hairpin loops

  22. Slide 22: Single Guide RNA (sgRNA)

    explorer.bio-rad.com Single Guide RNA (sgRNA) 20-nucleotide guiding region scaffold region hairpin loops

  23. Slide 23: Cas = CRISPR Associated (restriction enzyme)

    explorer.bio-rad.com Cas = CRISPR Associated (restriction enzyme) Target sequence

  24. Slide 24: explorer.bio-rad.com

    explorer.bio-rad.com

  25. Slide 25: explorer.bio-rad.com

    explorer.bio-rad.com

  26. Slide 26: Key Knowledge: Double Stranded Breaks are LETHAL

    Key Knowledge explorer.bio-rad.com Double Stranded Breaks are LETHAL

  27. Slide 27: Cut Repair

    explorer.bio-rad.com Cut Repair Non-homologous Homology directed end joining repair (NHEJ)

  28. Slide 28: lacZ

    explorer.bio-rad.com lacZ lacZ

  29. Slide 29: lacZ Beta-galactosidase X-gal

    explorer.bio-rad.com lacZ Beta-galactosidase X-gal Blue pigment

  30. Slide 30: Cut Repair: Cas9 protein

    explorer.bio-rad.com Cut Repair Cas9 protein Always on in our cells

  31. Slide 31: Cut Repair: Single Guide RNA

    explorer.bio-rad.com Cut Repair Single Guide RNA Delivered via a plasmid

  32. Slide 32: Cut Repair: Target DNA

    explorer.bio-rad.com Cut Repair Target DNA

  33. Slide 33: Cut Repair: Cut site

    explorer.bio-rad.com Cut Repair Cut site

  34. Slide 34: Cut Repair

    explorer.bio-rad.com Cut Repair

  35. Slide 35: Cut Repair

    explorer.bio-rad.com Cut Repair

  36. Slide 36: Cut Repair: Donor DNA

    explorer.bio-rad.com Cut Repair Donor DNA Delivered via a plasmid

  37. Slide 37: Cut Repair

    explorer.bio-rad.com Cut Repair

  38. Slide 38: Cut Repair: Homology directed repair

    explorer.bio-rad.com Cut Repair Repair machinery Homology directed repair

  39. Slide 39: Cut Repair

    explorer.bio-rad.com Cut Repair lacZ Repair machinery lacZ Homology directed repair

  40. Slide 40: Cut Repair: Stop codon

    explorer.bio-rad.com Cut Repair STOP lacZ Stop codon lacZ STOP Homology directed repair

  41. Slide 41: lacZ

    explorer.bio-rad.com lacZ lacZ

  42. Slide 42: Heat shock tubes

    explorer.bio-rad.com • Heat shock tubes at 60°C for exactly 50 seconds. • Note: can also use sous vide. If using dry bath, fill wells with a bit of water. • Put tubes back on ice for 2 minutes.

  43. Slide 43: Add LB broth to each tube

    explorer.bio-rad.com • Add 250 µl of LB broth to each tube. • Incubate at RT for 20 minutes. • Note: can also be incubated at RT overnight.

  44. Slide 44: lacZ Beta-galactosidase X-gal

    explorer.bio-rad.com lacZ Beta-galactosidase X-gal Blue pigment

  45. Slide 45: All starter cells have Cas9 being expressed all the time

    explorer.bio-rad.com All starter cells have Cas9 being expressed all the time

  46. Slide 46: Arabinose control of repair machinery

    explorer.bio-rad.com Arabinose control of repair machinery + arabinose – arabinose

  47. Slide 47: Double stranded breaks without repair machinery are LETHAL

    explorer.bio-rad.com Double stranded breaks without repair machinery are LETHAL

  48. Slide 48: Plasmids

    explorer.bio-rad.com Plasmids Donor DNA sgRNA pLZDonorGuide (pDG) pLZDonor (pD)

  49. Slide 49: explorer.bio-rad.com

    explorer.bio-rad.com

  50. Slide 50: Cas9, Guide RNA, Repair Mechanism, Donor DNA

    explorer.bio-rad.com Cas9 Guide RNA Repair Mechanism Donor DNA

  51. Slide 51: Controls! Why all the tubes?

    explorer.bio-rad.com Why all the tubes? Why not just do D? Controls!

  52. Slide 52: Cas9, Guide RNA, Repair Mechanism

    explorer.bio-rad.com Cas9 Guide RNA Repair Mechanism Donor DNA Bacteria Cas9, Guide Donor and Cas9 + Guide survive heat RNA Cuts repair alone do causes cut, shock nothing Donor DNA repair

  53. Slide 53: Example Results

    explorer.bio-rad.com Example Results A B C D

  54. Slide 54: Out of the Blue Genotyping Kit

    explorer.bio-rad.com Out of the Blue Genotyping Kit Extract chromosomal DNA Amplify DNA Electrophorese DNA Multiplex PCR

  55. Slide 55: Primer set 1: amplifies unmodified lacZ

    explorer.bio-rad.com Primer set 1: amplifies unmodified lacZ target gene editing site

  56. Slide 56: Primer set 2: amplifies edited lacZ

    explorer.bio-rad.com Primer set 2: amplifies edited lacZ insert

  57. Slide 57: Primer set 3: amplifies control DNA

    explorer.bio-rad.com Primer set 3: amplifies control DNA

  58. Slide 58: Predict results

    explorer.bio-rad.com Predict results

  59. Slide 59: Sample results

    explorer.bio-rad.com Sample results Lane Sample 1 Molecular weight ruler (MWR) 2 Positive PCR Control (+) 3 PCR Sample S 4 PCR Sample C 5 PCR Sample D1 6 PCR Sample D2 7 PCR Sample D3 8 Negative PCR Control (–)

  60. Slide 60: Label plates and add bacteria

    explorer.bio-rad.com • Label IX/SPT plates A, B, C, and D. A, B, C, & D • Use a fresh pipet to add 100 µl of bacteria from each tube (A, B, C, D) to the appropriate plate. • Incubate at 37° for overnight. • Note: can also be incubated at RT for 3-4 days.

  61. Slide 61: FREE Resources and Activities

    explorer.bio-rad.com FREE Resources and Activities bio-rad.com/teachcrispr

  62. Slide 62: Out of the Blue CRISPR Kit Website

    explorer.bio-rad.com Out of the Blue CRISPR Kit Website 62

  63. Slide 63: Applications of CRISPR

    explorer.bio-rad.com Applications of CRISPR

  64. Slide 64: Cell and Gene Therapies using CRISPR: Germ Line, Somatic

    explorer.bio-rad.com Cell and Gene Therapies using CRISPR Germ Line Somatic https://www.genome.gov/genetics-glossary https://en.wikipedia.org/wiki/File:Bougle_whole2_retouched.png

  65. Slide 65: Somatic Cell and Gene Therapies: In Vivo, Ex Vivo

    explorer.bio-rad.com Somatic Cell and Gene Therapies using CRISPR In Vivo Ex Vivo Modify patient Modify virus or cells and return other delivery them to the patient system Autologous Second wave -from patient -delivery -immune system Allogenic -universal cells

  66. Slide 66: Ex Vivo: Sickle Cell Disease Background

    explorer.bio-rad.com Ex Vivo: Sickle Cell Disease Background SNP at rs334 in Hemoglobin β GAG Glu GTG Val https://www.nhlbi.nih.gov/health-topics/sickle-cell-disease

  67. Slide 67: Ex Vivo: Sickle Cell

    explorer.bio-rad.com Ex Vivo: Sickle Cell HPSC

  68. Slide 68: Ex Vivo: Sickle Cell + β-thalassemia: CTX001 Rx

    explorer.bio-rad.com Ex Vivo: Sickle Cell + β-thalassemia: CTX001 Rx Fetal Adult 2021 α γ BCL11A α β 2 patients γ α Transcription factor β α 100 Disrupt α repression of Globin (%) BCL11A fetal hemoglobin γ Repressor on fetal hemoglobin Symptoms elimination of β Onset vaso-occlusive 0 episodes -9 -6

  69. Slide 69: Ex Vivo: CTX001 Rx – Patient view

    explorer.bio-rad.com Ex Vivo: CTX001 Rx – Patient view Apheresis Myeloablation CTX001 Infusion Transfusion

  70. Slide 70: Ex Vivo: CTX001 Rx – Lab View

    explorer.bio-rad.com Ex Vivo: CTX001 Rx – Lab View Apheresis HPSC isolation Manufacturing Electroporation Storage Flow Cytometry Sequencing/Bioinformatics

  71. Slide 71: Ex Vivo: CAR-T Therapy

    explorer.bio-rad.com Ex Vivo: CAR-T Therapy Chimeric Antigen Receptor (CAR) T Cell Therapy Reyasingh56 - Own work, CC BY-SA 4.0 Reprogram T- Cells to recognize cancer cells ZFNs and TALENS have been the only editing tools used for clinical trials 7 ClinicalTrials.gov currently recruiting for CRISPR

  72. Slide 72: Label plates and add bacteria

    explorer.bio-rad.com • Label IX/SPT plates A, B, C, and D. A, B, C, & D • Use a fresh pipet to add 100 µl of bacteria from each tube (A, B, C, D) to the appropriate plate. • Incubate at 37° for 2 days. • Note: can also be incubated at RT for 3-4 days.

  73. Slide 73: Ex Vivo: CAR-T Therapy for Cancer

    explorer.bio-rad.com Ex Vivo: CAR-T Therapy for Cancer Cancer Cell Extracellular VH VL antigen Monoclonal AB Transmembrane CAR-T 4 -1BB, etc. Intracellular Stimulatory roles including ILs CD28, etc. CD3-ζ Activates cytotoxic and helper T cells + More to come: safe switches, etc

  74. Slide 74: In Vivo: Leber Congenital Amaurosis / LCA10

    explorer.bio-rad.com In Vivo: Leber Congenital Amaurosis / LCA10 Disease Background Inherited retinal dystrophy Severe visual impairment Early onset SNP in CEP290 leads to aberrant splice donor inserting a stop codon disrupting photoreceptor function

  75. Slide 75: In Vivo: LCA10: EDIT-1 Rx

    explorer.bio-rad.com In Vivo: Leber Congenital Amaurosis/LCA10: EDIT-1 Rx SNP 2020 First Human Exon 26 Exon 27 Phase 1 Subretinal injection Eye low immune surveillance deletion Only need 10% success Adeno-Associate Virus 5 packed with 2 gRNAs and Cas9

  76. Slide 76: In Vivo: Urinary Tract Infections: LBP-EC01 Rx

    explorer.bio-rad.com In Vivo: Urinary Tract Infections: LBP-EC01 Rx Chronic UTI due to catheterization Phage genes CASCADE-Cas3 E.coli target crRNA Bacteriophage + CRISPR-Cas3 - ssDNA nuclease destroys gDNA Cas3 - Bacteriophage lytic Bacterial Genome Phase 1b clinical trial complete

  77. Slide 77: Instructor Prep

    explorer.bio-rad.com Instructor Prep

  78. Slide 78: Prep supplies

    explorer.bio-rad.com Prep supplies • 1 L flask • 3 500 ml flasks • microwave (or hot plate) • 250 ml graduated cylinder • distilled water • scale (accuracy to 0.1 g) • p200 micropipet and tips

  79. Slide 79: Rehydrate arabinose and spectinomycin

    explorer.bio-rad.com • Rehydrate arabinose with 3 ml dH20 • Rehydrate spectinomycin with 0.5 dH20

  80. Slide 80: Label flasks

    explorer.bio-rad.com • Label 1 500 ml flask “KIX” • Label 2 500 ml flasks “KIX/SPT”

  81. Slide 81: Add dH2O to a 1 L flask

    explorer.bio-rad.com • Add 700 dH20 to a 1 L flask

  82. Slide 82: Add dH2O to KIX Mix bottle

    explorer.bio-rad.com • Add 3 ml dH20 to KIX Mix bottle. • Add the 3 ml of KIX Mix to the flask. • Rinse the KIX Mix bottle 2 more times with 3 ml of dH20 *Rinse 3 times total to clean out the bottle.

  83. Slide 83: Add dH2O to KIX Mix bottle

    explorer.bio-rad.com • Add 3 ml dH20 to KIX Mix bottle. • Add the 3 ml of KIX Mix to the flask. • Rinse the KIX Mix bottle 2 more times with 3 ml of dH20 to clean out the bottle.

  84. Slide 84: Add LB agar to flasks

    explorer.bio-rad.com • Add 7 g LB agar to KIX flask. • Add 9 g LB agar to KIX/SPT flasks. • Swirl to mix.

  85. Slide 85: Microwave until just boiling

    explorer.bio-rad.com • Microwave until just boiling. Swirl to mix. • Bring to a boil two more times. • Make sure there are no swirlies floating around. • Let cool until you can handle flasks.

  86. Slide 86: Label plates

    explorer.bio-rad.com • Label plates • Shortcut: use stripes for each type of plate: 1 for IX, 2 for IX/Ara, no stripe for IX/SPT. • Note: get an extra case of plates if you want to pour extras of each type.

  87. Slide 87: Pour KIX plates

    explorer.bio-rad.com • Use KIX agar and pour 8 IX plates

  88. Slide 88: Add arabinose and pour IX/Ara plates

    explorer.bio-rad.com • Add 1 ml rehydrated arabinose to remaining KIX agar. Swirl to mix. • Pour 8 IX/Ara plates

  89. Slide 89: Cool flasks, add spectinomycin, pour plates

    explorer.bio-rad.com • Let 2 KIX/SPT flasks cool until they aren’t hot against your x2 cheek (less than 60°C). • Add 250 µl of spectinomycin to each flask. Swirl to mix. • Pour 40 KIX/SPT plates. • Let cure in the dark at room temp for 2 days.

  90. Slide 90: Prepare LB broth

    explorer.bio-rad.com • Add LB capsule to 50 ml dH20 in a 150 to 250 ml bottle with microwave-proof cap. Cap loosely. • Microwave to boiling 3 times. • Tighten lid and let cool to room temperature.

  91. Slide 91: Rehydrate E. coli with LB broth

    explorer.bio-rad.com • Rehydrate E. coli with 250 µl LB broth. • Incubate at room temperature or 37°C overnight.

  92. Slide 92: Streak plates with E. coli

    explorer.bio-rad.com • Streak 8 IX plates and 8 IX/Ara plates with E. coli. 8 IX and 8 IX/Ara

  93. Slide 93: Dispense transformation solution and LB broth

    explorer.bio-rad.com • Dispense 1.2 ml of transformation solution to 8 tubes labeled “TS.” • Dispense 1.2 ml of LB broth to 8 tubes labeled “LB.” x8 x8

  94. Slide 94: Dispense pLZ Donor and DonorGuide

    explorer.bio-rad.com • Dispense 25 µl of pLZ Donor to 8 tubes labeled “pD.” • Dispense 25 µl of pLZ DonorGuide to 8 tubes labeled “pDG.” x8 x8

  95. Slide 95: CRISPR-Cas9 Paper Model

    explorer.bio-rad.com CRISPR-Cas9 Paper Model

  96. Slide 96: explorer.bio-rad.com

    explorer.bio-rad.com CEZD gg

  97. Slide 97: Part 1. Simulate the Molecular Mechanism of Cas9 DNA Cleavage

    explorer.bio-rad.com Part 1. Simulate the Molecular Mechanism of Cas9 DNA Cleavage

  98. Slide 98: PAM, 20 nucleotide sequence, Single guide RNA

    explorer.bio-rad.com PAM 20 nucleotide Single guide RNA sequence

  99. Slide 99: sgRNA Binds; sgRNA – Cas9 interrogates DNA

    explorer.bio-rad.com sgRNA Binds sgRNA – Cas9 interrogates DNA

  100. Slide 100: PAM sequence allows Cas9 to open DNA

    explorer.bio-rad.com PAM sequence allows Cas9 to open DNA and see and 20 Nucleotide Target sequence matches on sgRNA If match occurs Cas9 Cuts 3 basepairs 5’ from PAM sequence (in the sgRNA)

  101. Slide 101: Thinking around the model!

    explorer.bio-rad.com Thinking around the model!

  102. Slide 102: Thinking around the model!

    explorer.bio-rad.com Thinking around the model! 20 No, the sgRNA region is directly upstream (5’) of the PAM Cas9 cuts three bases upstream (5’) of the protospacer sequence

  103. Slide 103: Part 1. Simulate the Molecular Mechanism of Cas9 DNA Cleavage

    explorer.bio-rad.com Part 1. Simulate the Molecular Mechanism of Cas9 DNA Cleavage

  104. Slide 104: Guide RNA Binding Area

    explorer.bio-rad.com Allee GelclebUsleieUclseulla rn Vv Pad Guide RNA Binding Area

  105. Slide 105: explorer.bio-rad.com

    explorer.bio-rad.com AABBEECEEVERCUCEEUUA ) y), (210-AAD)

  106. Slide 106: explorer.bio-rad.com

    explorer.bio-rad.com VOVOLODLILSOODLOLOVVLILSVOOLOV- €& 3 - GTAGACACCACGT TGCCCGCGACCEAGCCAATGCG CTGTCAGCAAAG GACTTAAACTGGACT- 5 walcleeieicecUeleleUlcieieu ula ) y)

  107. Slide 107: explorer.bio-rad.com

    3 - GTAGACACCACGTTGCCCGCG explorer.bio-rad.com CTGTCAGCAAAG VOVOLODLILSOODLOLOVVLILSVOOLOV- €& GACTTAAACT CT- 5 alciebieciecueieleucieleuyrs

  108. Slide 108: explorer.bio-rad.com

    AGAGACCACGT TGCCCGCGACCCA explorer.bio-rad.com VOVOLODLILSOODLOLOVVLILSVOOLOV- €& CTGTCAGCAAAG GACTTAAACT CT- 5 alciebielciecueleeulcieleuyArs

  109. Slide 109: explorer.bio-rad.com

    G- OWLOL 3 - GTAGAC ICCAC TTGCCCGCGACCCAGCCAAT explorer.bio-rad.com CTGTCAGCAAAG GACTTAAACT VOVOLODLILSOODLOLOVVLILSVOOLOV- €& CT- 5 alciebieciecueieleucieleuyrs

  110. Slide 110: explorer.bio-rad.com

    explorer.bio-rad.com G- OWLOL 3 - GTAGACACCACGT TGCCCGCGACCCAGCCAATGCC CTGTCAGCAAAG VOVOLODLILSOODLOLOVVLILSVOOLOV- €& GACTTAAACT CT- 5 AnbadeceCUeECUCcEUUN yy,

  111. Slide 111: explorer.bio-rad.com

    explorer.bio-rad.com G- OWLOL ICCACGT TGCCCGCGACCCAGCCAATGCC'! 3 - GTAGAC CTGTCAGCAAAG VOVOLODLILSOODLOLOVVLILSVOOLOV- €& GACTTAAACT CT- 5 AnbadececUeecuCcUUN yy,

  112. Slide 112: explorer.bio-rad.com

    explorer.bio-rad.com G- OWLOL VOVOLODLLILSOND LOLS VVLLILSVOOLSV- & CTGTCAGCAAAG GACTTAAACT CT- § AabaceceCUescUCGEUU y)

  113. Slide 113: explorer.bio-rad.com

    explorer.bio-rad.com Allee eelclebUsleieUclseulla

  114. Slide 114: CRISPR-Cas9 Cut and Repair

    explorer.bio-rad.com CRISPR-Cas9 Cut and Repair Cut Repair Cas9-sgRNA complex Homology directed repair Non-homologous end joining

  115. Slide 115: Activity (3) — Mathematical Modeling

    explorer.bio-rad.com Activity (3) — Mathematical Modeling From Out of the Blue CRISPR Kit Student Guide

  116. Slide 116: Activity — Mathematical Modeling

    explorer.bio-rad.com Activity — Mathematical Modeling How many times would you expect to find a specific 20 base pair sequence in the human genome? X 3.23 x 10 9 = Frequency of sequence Human Genome Times expected “Once in 4^20 bases”

  117. Slide 117: Off-Target Cutting

    explorer.bio-rad.com Off-Target Cutting ● Why might it happen? ● How might it be stopped?

  118. Slide 118: Part 2. Design the Guiding Region of an sgRNA

    explorer.bio-rad.com Part 2. Design the Guiding Region of an sgRNA Sequence from lacZ gene

  119. Slide 119: Guide RNA Binding Area

    explorer.bio-rad.com Guide RNA Binding Area BIO-RAD

  120. Slide 120: explorer.bio-rad.com

    explorer.bio-rad.com

  121. Slide 121: explorer.bio-rad.com

    explorer.bio-rad.com

  122. Slide 122: CAGACGGC AAA CGACU GUCC

    explorer.bio-rad.com CAGACGGC AAA CGACU GUCC

  123. Slide 123: Record sgRNA sequence and focus questions

    explorer.bio-rad.com 4. Record your final sequence below or in a notebook. a sgRNA guiding region sequence ® A Focus questions A. Describe in complete sentences how the requirement of a PAM sequence affects the flexibility of CRISPR-Cas9 gene editing. @ B. Describe in complete sentences how you woul

  124. Slide 124: CAGACGGC AAA CGACU GUCC

    explorer.bio-rad.com CAGACGGC AAA CGACU GUCC The PAM sequences limits the flexibility of where the CRISPR-Cas9 system can cut because it needs to have a PAM 3 nucleotides away, so not all exact locations in genome can be edited To design a target DNA cleavage site I would look for PAM sites and then

  125. Slide 125: Part 4. Design Donor Template DNA for DNA Repair

    explorer.bio-rad.com Part 4. Design Donor Template DNA for DNA Repair Cut Repair Cas9-sgRNA complex Homology directed repair Non-homologous end joining

  126. Slide 126: explorer.bio-rad.com

    explorer.bio-rad.com RAB SEC USEC UCEEUUAS —— J

  127. Slide 127: explorer.bio-rad.com

    explorer.bio-rad.com G- OWLOL LOOVY 999 4 iL 0) VOVOLODLLILSOND LOLS VVLLILSVOOLSV- & 3 - GTAGACACCACGT TGCCCGCGACCCAGCC AATGCC TMU UUII CT- § , “TIE Er nud THAT | CTT “TUTTI it GCCCGCGACCCAGCC| | | | | | | | | | | | JAATGCC ] BIO

  128. Slide 128: Desired Change, Donor Template DNA Sequence, Focus questions

    explorer.bio-rad.com Desired Change Donor Template DNA Sequence Cause a frameshift Insert an EcoRI restriction site Focus questions A. Describe two possible advantages of using HDR over using NHEJ in a gene editing experiment. B. Describe two possible advantages of using NHEJ over using HDR in a gen

  129. Slide 129: Frameshift and donor template design considerations

    explorer.bio-rad.com ATG GG GCT AT ATG GAA TTC ATT + control frame shifts + add stop codon (TAG, TAA, TGA) + cost - don’t have to add donor DNA + protocol time – one less transformation Cause two double stranded breaks (2 sgRNA) and have donor template cover the region deleted but have at T changed

Bio-Rad Laboratories — Technical Presentation (2022) on 6ix